White cell scanning for inflammatory bowel disease: are biochemical markers useful referral criteria?

Nuclear Medicine Communications

Volumn 24, Issue 11, 2003, Pages 1145-1148

  Kerry, J E ^a   Marshall, C ^a   Griffiths, P A ^a   Scott, B B ^a   Griffiths, G ^a  

^a Gastroenterology   (United Kingdom)

Author keywords

Biological markers; Inflammatory bowel disease; Radionuclide imaging; Referral and consultation

Indexed keywords

ACID GLYCOPROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHYMOTRYPSIN INHIBITOR; GLYCOPROTEIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BIOCHEMISTRY; CALCULATION; CELL LABELING; ENTERITIS; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; PROTEIN DETERMINATION; SCINTISCANNING; STANDARD;

ADOLESCENT; ADULT; AGED; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; FEMALE; GLYCOPROTEINS; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTES; MALE; MIDDLE AGED; PATIENT SELECTION; RADIOPHARMACEUTICALS; REFERRAL AND CONSULTATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERPINS; STATISTICS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 10344237615     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200311000-00004     Document Type: Article

References (11)

1. Calvin J, Neale G, Fotherby KJ, Price CP. The relative merits of acute phase proteins in the recognition of inflammatory conditions. Ann Clin Biochem 1988; 25: 60-66.
2. 99mTc-HMPAO. Nucl Med Commun 1988; 9: 465-475.
3. Fagan EA, Dyck RF, Maton PN, Hodgson HJ, Chadwick US, Petrie A, et al. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982; 12: 351-359.
4. Forbes A. Clinicians' guide to inflammatory bowel disease. London: Chapman & Hall Medical, 1997.
5. The Ionising Radiation (Medical Exposure) Regulations 2000. Statutory Instrument 2000 No. 1059. London: The Stationery Office Ltd, 2000.
6. Hope RA, Longmore JM, McManus SK, Wood-Allum CA. Oxford handbook of clinical medicine. Oxford: Oxford University Press, 1998.
7. Roca M, Martin-Comin J, Becker W, Bernardo-Filho M, Gufilen B, Moisan A, et al. A consensus protocol for white blood cells labeling with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1998; 25: 797-799.
8. Weldon MJ, Lowe C, Joseph AEA, Maxwell JD. Quantitative leukocyte scanning in the assessment of inflammatory bowel disease activity and its response to therapy. Aliment Pharmacol Ther 1996; 10: 123-132.
9. Prantera C, Davoli M, Lorenzetti R, Pallone F, Marcheggiano A, Iannoni C, et al. Clinical and laboratory indicators of extent of ulcerative colitis. J Clin Gastroenterol 1988; 10: 41-45.
10. Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Barnes W. Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications. Nucl Med Commun 1988; 9: 693-701.
11. Shine B, Berghouse L, Jones JEL, Landon J. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta 1985; 148: 105-109.